Annual General Meeting

GlaxoSmithKline plc (‘GSK’) holds an Annual General Meeting in London each year during May. All the directors able to attend are available formally during the meeting, and informally beforehand, for questions.

Voting on all resolutions put to the Annual General Meeting is done by way of a poll rather than by a show of hands.

2019 Annual General Meeting

The nineteenth Annual General Meeting (‘AGM’) of GSK was held on Wednesday 8 May 2019 at the Sofitel London Heathrow, Terminal 5, London Heathrow Airport, TW8 2GD.

The 2019 Notice of AGM (PDF - 261.8KB) gives details on the resolutions put to the meeting, together with explanatory notes.

All resolutions were passed at the AGM and the voting results can be found here.

In accordance with section 311A of the Companies Act 2006, GSK confirms that, as at 1 April 2019, its issued share capital (excluding Treasury shares) consisted of 4,987,659,065 ordinary shares of 25 pence each, carrying one vote each. Therefore, the total voting rights that members are entitled to exercise at the AGM in respect of these shares is 4,987,659,065.

Information about our previous Annual General Meetings is available from the AGM archive tab above.

Notice of Availability

2019 General Meeting – Proposed transaction with Pfizer, Inc to form a new Consumer Healthcare Joint Venture.

Information on the General Meeting held on Wednesday 8 May (immediately following the AGM) can be found here.